Showing results (2611-2620 of 2,949) with videos related to

Sort By:
Pageof 295
Neurology|November 4, 2024
Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer DiseaseMichelle Safransky, Jenna R Groh, Kaj Blennow, et al.
The Lancet. Oncology|September 21, 2010
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium studyKeith C Bible, Vera J Suman, Julian R Molina, et al.
JAMA Neurology|July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle AgeCourtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.
BMC Neurology|November 12, 2016
Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40Yuetiva Deming, Kathleen Black, David Carrell, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2022
Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument-Short FormTaylor Howell, Shilpa Gummadi, Chau Bui, et al.
The Journal of Investigative Dermatology|June 10, 2017
Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and HumansSusan H Smith, Channa Jayawickreme, David J Rickard, et al.
Head & Neck|August 3, 2018
AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid SurgeonsBrendan C Stack, Neil S Tolley, Twyla B Bartel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAzadeh Feizpour, Pierrick Bourgeat, Vincent Dore, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's diseasePatrick Oeckl, Benjamin Mayer, Randall J Bateman, et al.
Nature Immunology|August 23, 2022
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulationAlan Kennedy, Erin Waters, Behzad Rowshanravan, et al.
Pageof 295